Viewing Study NCT06117709



Ignite Creation Date: 2024-05-06 @ 7:43 PM
Last Modification Date: 2024-10-26 @ 3:12 PM
Study NCT ID: NCT06117709
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-04-30
First Post: 2023-10-31

Brief Title: Integrated Smartphone Technology to Alleviate Malignant Pain I-STAMP Testing
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute

Study Overview

Official Title: Integrated Smartphone Technology to Alleviate Malignant Pain I-STAMP Development Usability and Acceptability Testing
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of the study is to evaluate if the smartphone app I-STAMP Integrated Smartphone Technology to Alleviate Malignant Pain helps participants with cancer pain manage symptoms and keep track of medications
Detailed Description: The goal of this study is to develop and refine I-STAMP Integrated Smartphone Technology to Alleviate Malignant Pain an electronic health record-integrated mobile health mHealth application designed to support advanced cancer patients and care teams in pain management

The research study procedures include screening for eligibility surveys and interviews It is expected that up to 73 participants will take part in this research study Activities 1-3 are non-interventional and will be used to collect data for application development

Activity 4 This activity will be interventional and will be added with a future amendment

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None